9th Imaging in Cancer Drug Development

-

Join SMI at the anticipated 9th annual Imaging in Cancer Drug Development conference in March 2013 that will be the ultimate opportunity to witness presentations on the current developments surrounding oncology, pre-clinical & clinical imaging, technical innovations and advancements, imaging biomarkers in cancer drug development and the future of imaging.

With a reputation for attracting the industry’s leading figures, this year's agenda offers an unmatched opportunity for debate and resolution of key challenges and current advances in oncology imaging.

KEY TOPICS FOR 2013 INCLUDE:

• Latest developments in fluorescence and bioluminescence for drug monitoring in xenografts
• Novel target identification and lead discovery in preclinical biomarkers and radiochemistry
• Strengths and limitations of whole body optical imaging with X-ray micro CT and multiphoton intravital microscopy
• Overcoming challenges in nuclear tracers for multiscale imaging in oncology
• Current application of PET/SPET modalities and a review of PFS (progression-free survival)
• Practical tools for business expansion in the current economic climate

Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

13 Mar 2013

UPCOMING FEATURED EVENTS 1 2 Next 
2014 ASCB/IFCB Meeting6 Dec 2014 Read
PepTalk: The Protein Science Week19 Jan 2015 Read
SLAS20157 Feb 2015 Read
Electronic Data in Clinical Trials24 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read


ALL UPCOMING EVENTS